Free Shipping Over £25!
Or click and collect!
Or click and collect!
What Public Health England and the NHS Say About Vaping
Health Guides
Public Health England and the NHS have some of the most clearly articulated positions on vaping of any health authorities in the world. Here is a comprehensive summary of what they say, why they say it and where their guidance has evolved.
~95%
PHE's Estimated Harm Reduction vs Smoking
2019
Landmark NEJM Trial Led to NHS Updating Cessation Guidance
Nuanced
Both Bodies Support Vaping for Smokers, Not for Non-Smokers
Why UK guidance matters
Why the UK Health Establishment's Position on Vaping Is Important
The UK has one of the most evidence-based and clearly articulated public health positions on vaping in the world. Public Health England (now incorporated into the UK Health Security Agency and the Office for Health Improvements and Disparities), NHS England and bodies including Cancer Research UK and the Royal College of Physicians have all published considered positions on vaping that are substantially more nuanced and evidence-grounded than the approach taken in many other countries. Understanding what these bodies actually say, rather than media interpretations of their positions, gives vapers and smokers the most accurate picture available.
Public Health England was reorganised into UKHSA and OHID in 2021. Guidance originally published under PHE continues to represent the UK government's evidence-based position and has been maintained and updated by successor bodies.
The key positions
What the UK Health Bodies Say About Vaping
The 2015 PHE Evidence Review: the Foundation
Public Health England's 2015 evidence review on e-cigarettes is the most widely cited single document in UK vaping policy. Its central finding, that vaping is approximately 95% less harmful than smoking, provided the evidence-based foundation for the UK's harm reduction approach to vaping. The review was conducted by an independent team of researchers who assessed the available evidence on vaping's health effects relative to smoking. The 95% figure has been contested and clarified over the years but the underlying finding, that vaping is substantially less harmful than smoking, has been maintained and broadly supported by subsequent research.
NHS Cessation Guidance: Vaping Is Now Recommended
Following the 2019 New England Journal of Medicine randomised controlled trial showing vaping combined with behavioural support produced 18% one-year quit rates compared to 9.9% for NRT, NHS cessation guidance was updated to explicitly recommend vaping as a cessation tool for smokers. The NHS describes vaping as the most effective consumer nicotine product for smoking cessation. NHS Stop Smoking services now offer support to people who use vaping as their cessation method. This represents a significant shift from earlier equivocal NHS positions to active recommendation.
The Consistent Qualification: Not Risk-Free
Both PHE and the NHS consistently qualify their support for vaping with the statement that vaping is not risk-free. This qualification is important and honest. Neither body describes vaping as safe, they describe it as substantially less harmful than smoking. The distinction matters: it is a harm reduction recommendation, not a safety endorsement. This nuance is frequently lost in media reporting that either exaggerates vaping's safety (citing 95% reduction without the qualification) or exaggerates its danger (ignoring the comparison with smoking).
Clear Guidance That Non-Smokers Should Not Vape
Both PHE and the NHS are explicit that the harm reduction case for vaping applies to smokers switching away from cigarettes, not to non-smokers, young people or anyone who would otherwise not use nicotine. The official guidance consistently states that non-smokers should not take up vaping. This is the clearest boundary in UK vaping policy and one that is sometimes overlooked in harm reduction discussions.
Cancer Research UK's Position
Cancer Research UK describes vaping as significantly less harmful than smoking and supports its use as a cessation tool. It states that the evidence to date does not show vaping to be a cause of cancer while acknowledging that long-term data is limited. It recommends that non-smokers do not vape. This is the same nuanced harm reduction position as PHE and NHS, consistent across the UK's major health bodies.
Royal College of Physicians
The RCP has been among the most consistent and early supporters of vaping as a harm reduction tool. Its 2016 report Nicotine Without Smoke recommended that vaping be made more accessible and affordable to smokers and described the risk of vaping as unlikely to exceed 5% of the harm of smoking. The RCP has maintained and updated this position and remains one of the clearest institutional voices supporting vaping within the harm reduction framework.
"When customers cite something they read online claiming vaping is dangerous, we always point them to the NHS and PHE guidance first. The UK's public health position is well-reasoned and grounded in actual evidence."
Touch of Vape team, CoventryWhere guidance has evolved
How UK Guidance Has Changed Over Time
01
From cautious to actively supportive: 2015 to 2019
PHE's 2015 review established the harm reduction baseline. The 2019 NEJM trial evidence moved NHS guidance from cautious acknowledgement of vaping to active recommendation as a cessation tool. This was a significant shift driven by clinical trial evidence.
02
The youth vaping concern has grown
As vaping has become more prevalent among young people who have never smoked, both PHE and the NHS have strengthened their messaging around never-smoker and under-18 vaping. The harm reduction framing has always excluded non-smokers but this boundary has been emphasised more strongly as youth uptake has increased.
03
Flavour and product restrictions: ongoing discussion
UK regulators continue to discuss flavour restrictions and product standards in the context of youth appeal versus adult cessation utility. The balance between making vaping attractive enough to help adult smokers switch and not making it so attractive that it recruits non-smokers remains an active policy tension.
04
Long-term evidence continues to develop
Both bodies acknowledge that the long-term evidence base is still developing. UK guidance will continue to evolve as longer-term follow-up data on vaping health outcomes becomes available. The current guidance reflects the best available evidence at this time.
Touch of Vape Coventry
Questions About UK Vaping Policy and Guidance? Our Coventry Team Is Here
We follow the evidence and the guidance. Come in for a conversation grounded in what the UK's health bodies actually say.
To find our Coventry store, visit our Vape Shop Coventry page.
From our Health guide
Part of our Health guide
Health Guides
Our Health guide covers UK vaping policy, the evidence base behind it and what the key health bodies actually say, written to help you understand the genuine state of the guidance.
Find more policy and evidence guides in our Health guide.
More from our Health Guides
Related Health Articles
Understanding What the NHS and PHE Actually Say? Our Coventry Team Has Read It.
Evidence-based guidance from a team that takes the science seriously.